INFOGRAPHIC: A US biotech IPO surge? Data are mixed

Many people argue that the surge in initial public offerings by biotechnology companies suggests a bubble in danger of imminent explosion, but is the industry's IPO market really surging? It depends on how you interpret the numbers related to first-time stock offerings so far in 2014 versus 2015.